Interneuron, Wyeth-Ayerst sales and marketing update

The companies launched sales of IPIC's Redux dexfenfluramine for obesity. IPIC will promote the drug through a 30-person sales force targeted at physician specialists.

Wyeth-Ayerst, a division of American Home Products Corp., will sell to a broader target audience, including general practitioners, through its 1,500 sales reps. ...